245 related articles for article (PubMed ID: 9918218)
21. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation.
Padgett LC; Lui GM; Werb Z; LaVail MM
Exp Eye Res; 1997 Jun; 64(6):927-38. PubMed ID: 9301473
[TBL] [Abstract][Full Text] [Related]
22. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17.
Bamba S; Andoh A; Yasui H; Araki Y; Bamba T; Fujiyama Y
J Gastroenterol; 2003; 38(6):548-54. PubMed ID: 12825130
[TBL] [Abstract][Full Text] [Related]
24. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.
Airola K; Karonen T; Vaalamo M; Lehti K; Lohi J; Kariniemi AL; Keski-Oja J; Saarialho-Kere UK
Br J Cancer; 1999 May; 80(5-6):733-43. PubMed ID: 10360651
[TBL] [Abstract][Full Text] [Related]
25. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
London CA; Sekhon HS; Arora V; Stein DA; Iversen PL; Devi GR
Cancer Gene Ther; 2003 Nov; 10(11):823-32. PubMed ID: 14605668
[TBL] [Abstract][Full Text] [Related]
26. Effects of nifedipine and interleukin-1alpha on the expression of collagen, matrix metalloproteinase-1, and tissue inhibitor of metalloproteinase-1 in human gingival fibroblasts.
Sakagami G; Sato E; Sugita Y; Kosaka T; Kubo K; Maeda H; Kameyama Y
J Periodontal Res; 2006 Aug; 41(4):266-72. PubMed ID: 16827719
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells.
Stearns ME; Kim G; Garcia F; Wang M
Mol Cancer Res; 2004 Jul; 2(7):403-16. PubMed ID: 15280448
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
[TBL] [Abstract][Full Text] [Related]
29. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
30. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
Miyata Y; Kanda S; Nomata K; Hayashida Y; Kanetake H
Urology; 2004 Mar; 63(3):602-8. PubMed ID: 15028476
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinases MMP-2, -9 and tissue inhibitors TIMP-1, -2 expression and secretion by primary human osteoblast cells in response to titanium, zirconia, and alumina ceramics.
Oum'hamed Z; Garnotel R; Josset Y; Trenteseaux C; Laurent-Maquin D
J Biomed Mater Res A; 2004 Jan; 68(1):114-22. PubMed ID: 14661256
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes.
Pufe T; Harde V; Petersen W; Goldring MB; Tillmann B; Mentlein R
J Pathol; 2004 Mar; 202(3):367-74. PubMed ID: 14991903
[TBL] [Abstract][Full Text] [Related]
33. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
[TBL] [Abstract][Full Text] [Related]
34. Angiogenesis in vestibular schwannomas: expression of extracellular matrix factors MMP-2, MMP-9, and TIMP-1.
Møller MN; Werther K; Nalla A; Stangerup SE; Thomsen J; Bøg-Hansen TC; Nielsen HJ; Cayé-Thomasen P
Laryngoscope; 2010 Apr; 120(4):657-62. PubMed ID: 20205165
[TBL] [Abstract][Full Text] [Related]
35. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
Kim JR; Kim CH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474
[TBL] [Abstract][Full Text] [Related]
36. IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10.
Nold M; Goede A; Eberhardt W; Pfeilschifter J; Mühl H
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):68-75. PubMed ID: 12616343
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinases and their inhibitors.
Kugler A
Anticancer Res; 1999; 19(2C):1589-92. PubMed ID: 10365151
[TBL] [Abstract][Full Text] [Related]
38. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
39. Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
Jovanovic DV; Di Battista JA; Martel-Pelletier J; Reboul P; He Y; Jolicoeur FC; Pelletier JP
J Rheumatol; 2001 Apr; 28(4):712-8. PubMed ID: 11327240
[TBL] [Abstract][Full Text] [Related]
40. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]